LOGIN  |  REGISTER
Terns Pharmaceuticals
C4 Therapeutics

Integer to Present at Raymond James & Associates’ 46th Annual Institutional Investor Conference and KeyBanc Capital Markets Healthcare Forum

February 18, 2025 | Last Trade: US$78.88 0.17 0.22

PLANO, Texas, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Integer Holdings Corporation (NYSE: ITGR), a leading global medical device contract development and manufacturing organization (CDMO), today announced participation at the following upcoming investor conferences.

  • Integer will participate at the 2025 Raymond James & Associates’ 46th Annual Institutional Investor Conference, to be held March 3-5, 2025, in Orlando, Florida. Integer President and Chief Executive Officer Joseph Dziedzic is scheduled to present on Wednesday, March 5, 2025, at 11:00 a.m. ET.
  • Integer will participate at the 2025 KeyBanc Capital Markets Healthcare Forum, to be held virtually March 18-19, 2025. Integer President and Chief Executive Officer Joseph Dziedzic is scheduled to participate in a virtual fireside chat on Wednesday, March 19, 2025, at 9:45 a.m. ET.

A live webcast of each presentation will be accessible under “News & Events” on the Investor Relations section of the Integer website at investor.integer.net.

Learn more about Integer at www.integer.net.

About Integer®

Integer Holdings Corporation (NYSE: ITGR) is one of the largest medical device contract development and manufacturing organizations (CDMO) in the world, serving the cardiac rhythm management, neuromodulation, and cardio and vascular markets. As a strategic partner of choice to medical device companies and OEMs, the Company is committed to enhancing the lives of patients worldwide by providing innovative, high-quality products and solutions. The Company's brands include Greatbatch Medical® and Lake Region Medical®. Additional information is available at www.integer.net.

Investor Relations:
Andrew Senn
This email address is being protected from spambots. You need JavaScript enabled to view it.
763.951.8312 
Media Relations:
Kelly Butler
This email address is being protected from spambots. You need JavaScript enabled to view it.
469.731.6617

Stock Quote

Featured Stock

ClearPoint Neuro

ClearPoint Neuro is a global therapy-enabling platform company providing stereotactic navigation and delivery to the brain. Applications of our ClearPoint Neuro Navigation System include electrode lead placement, placement of catheters, and biopsy. The platform has FDA clearance and is...

CLICK TO LEARN MORE

Featured Stock

Recursion

Recursion Pharmaceuticals is a clinical stage TechBio company leading the space by decoding biology to industrialize drug discovery. Enabling its mission is the Recursion OS, a platform built across diverse technologies that continuously expands one of the world’s largest....

CLICK TO LEARN MORE

End of content

No more pages to load

Next page